The Develolpment of Aerosol Generating Procedure (AGP) Shields for Anaesthetic Use

麻醉用气溶胶发生程序 (AGP) 防护罩的开发

• 批准号: 73125
• 金额: $ 14.79万
• 依托单位: MANUFACTURING TECHNOLOGY CENTRE
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2020
• 资助国家: 英国
• 起止时间: 2020 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=73125
• 关键词: Develolpment; Aerosol; Generating; Procedure; AGP

The ability to manage the exposure of NHS staff to COVID-19 has been driven predominantly by the adoption of stringent PPE. Though effective, it does not reduce the viral load present in the working space, generally the hospital theatre, and does not address the concern that theatre capacity has been significantly diminished by the essential need to deep clean taking a longer time than before. The project will develop the application of a shield to address both issues. Firstly, through the reduction of viral load, the risk and consequences of exposure could be alleviated and, secondly, by containment within the shield. The project will improve theatre throughput back to a sustainable "new normal" state. The intent of the research project is to develop the production volume ready process required, conduct a service evaluation of the shield in a cohort of hospitals and to establish a logistical and business model for their wider use across the UK health support network.

管理英国国民健康保险制度工作人员接触新冠肺炎的能力，主要是由严格的个人防护措施推动的。虽然有效，但它并没有减少工作场所--通常是医院剧院--中存在的病毒载量，也没有解决由于需要比以前更长时间进行深度清洁而大大减少了剧院能力的关切。该项目将开发盾牌的应用，以解决这两个问题。首先，通过减少病毒载量，可以减轻暴露的风险和后果，其次，通过将病毒隔离在防护罩内。该项目将使影院吞吐量恢复到可持续的“新常态”状态。该研究项目的目的是开发所需的批量生产准备流程，在一组医院对盾牌进行服务评估，并为其在整个英国卫生支持网络中的更广泛使用建立一个后勤和商业模式。